| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 42.5 | 1,506.3 | 1,199.0 | 1,203.3 | 1,128.5 |
| Age-adjusted comparative prevalence of diabetes, % | - | 7.7 | 6.5 | 7.1 | 7.5 |
| People with undiagnosed diabetes, in 1,000s | - | - | 255.4 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 21.3 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 1,750.4 | 635.0 | 621.5 | 512.9 |
| Age-adjusted comparative prevalence of IGT, % | - | 9.6 | 3.5 | 3.9 | 4.2 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 381.8 | 377.8 | 341.4 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 2.2 | 2.4 | 2.5 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 18,433.0 | 24,212.5 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | 1.5 | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 0.3 | 0.0 | 0.3 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 0.4 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 1.2 | - | 2.2 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 3.9 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | - | 1,115.3 | 1,069.9 | 944.1 |
| Total diabetes-related health expenditure, ID million | - | - | 2,558.0 | 2,454.0 | 2,165.4 |
| Diabetes-related health expenditure per person, USD | - | 607.0 | 930.2 | 892.3 | 787.4 |
| Diabetes-related health expenditure per person, ID | - | - | 2,133.4 | 2,046.6 | 1,806.0 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 16,339.0 | 16,349.3 | 14,231.4 | 13,736.0 | 12,364.9 |
| Population of children (0-14 y), in 1,000s | 5,125.0 | - | 2,962.9 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 3,968.2 | - | - |